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Objective: To evaluate the family history of epilepsy in first degree relatives of probands with epilepsy.
Methods: A sample of 10 787 patients with epilepsy with complete information about first degree relatives (parents, siblings and
offspring) was selected from the database of the Episcreen Project, the largest Italian observational study on epilepsy. Family
history was assessed by: (1) prevalence estimates of epilepsy among proband’s relatives, (2) modified cumulative risks (MCR),
adjusted using proband’s age as censoring time in life tables, (3) standardised morbidity ratios (SMR), using a sub-group of
symptomatic epilepsies as control group.
Results: Patients (9.1%) had a family history of epilepsy. The overall prevalence of epilepsy among first degree relatives was
2.6%. Idiopathic generalised epilepsies had the highest prevalence (5.3%). Cryptogenetic epilepsies had a lower prevalence
(2.1%) than idiopathic epilepsies, but higher then symptomatic epilepsies (1.5%), both in generalised and focal forms (3.8%
vs. 2.0% and 1.8% vs. 1.3%). A similar tendency was detected using MCR and SMR, with the higher values of risks/ratios for
idiopathic and generalised epilepsies. Probands with idiopathic generalised epilepsies were highly concordant with respect to
their relatives’ type of epilepsy. Considering other strata factors, risks were higher in proband’s epilepsies with an onset less
then 14 years of age, while sex played no definite role in differentiating the family history.
Conclusions: The Episcreen model permits a variety of stratification factors to measure family risk, including age at onset,
epilepsy localisation and aetiology with a large sample of more than 10 000 probands and 1065/40 544 relatives affected and
classified.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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E. Cusani Visconti (S. Franceschetti, F. Panzica, G. Avanzini-MI);
P. Beffa Negrini, F. Cardinale (C. Munari , L. Tassi-MI); M.
Viri, C. Croce (A. Romeo-MI); F. Fittipaldi, C. Di Bonaven-
tura, F. Muzzi, F. Izzi (A.T. Giallonardo, M. Manfredi-RM);
C. Pachatz, R. Cilio (F. Vigevano, L. Fusco-RM); D. Del Pri-
ore, A. Piacenti, P. Pulitano (M.R. De Feo, G. Ricci-RM); I.
Sartori, L. Politini, N. Zanotta (A. Tartara-PV); M. Tripodi, C.
Gattuso (A. Magaudda, R. Di Perri-ME); P. Riguzzi, F. Muzzi
(C.A. Tassinari, R. Michelucci-BO); A. Cerullo, F. Bisulli (P.
Tinuper, E. Lugaresi-BO); R. Meo (S. Striano-NA); G. Car-
avaglios (O. Daniele, F. Piccoli-PA); G. Buzzi, F. Magnani (A.
Bianchi, P. Zolo-AR); Other Centres: M.T. Panozzo-P. Garofalo
(VI), M. Mastrangelo-G. Pastorino (MI), C. Zucca/L. Radice-G.
Spreafico (LC), A. Laneve/M.R. Mazzeo-L.M. Specchio (BA),
A. Vetro-G. Amodeo (AG), S. Calzolari-P. De Marco (TN),
INTRODUCTION
The importance of genetics in the aetiology of epilepsy
is well established1, 2. Twin studies have shown higher
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dizygotic twins and family studies have disclosed a
higher incidence of epilepsy in the proband’s relatives
as compared to the general population3–6. Genetic
factors play a major aetiologic role in idiopathic
epilepsy and a less important role in cryptogenetic and
symptomatic epilepsy7–9. Within idiopathic epilepsy,
some rare forms are characterised by Mendelian in-
heritance while the commonest forms show more
complex patterns of inheritance and family aggrega-
tion. A genetic mutation has been identified for rare
idiopathic epilepsies such as benign familial neonatal
convulsions10, 11, nocturnal frontal lobe epilepsy12
and generalised epilepsy with febrile seizures plus13,
whereas no mutation has been identified as yet for
the more common generalised and partial epileptic
syndromes, although some genetic loci have been
considered as possible candidates for harbouring this
mutation14.
Not surprisingly, a smaller number of genetic and
family studies are available for cryptogenetic and
symptomatic epilepsy, in which genetics play, by
definition, a minor role. It should nonetheless be
pointed out that mutated genes along with their al-
tered products have been identified for some rare
symptomatic epilepsies such as myoclonic progres-
sive epilepsy15, 16.
Family studies of epilepsy have hitherto been of
three types: (1) studies aimed at quantifying the
risk of epilepsy in the proband’s offspring and
siblings17–22, (2) studies of family history and genetic
risk in the relatives of probands with different epilep-
tic syndromes23–29 and (3) studies of phenotypic and
syndromic variability in families with many epilep-
tic subjects30–32. The family studies available in the
literature are difficult to compare on methodological
grounds because they employ different diagnostic
criteria and differ in the evaluation of febrile convul-
sions, isolated convulsions and convulsions secondary
to acute events. In many of these studies, family data
are obtained by history taking, making it difficult
to interpret events occurred during infancy. Another
limitation of these studies is that they exclude possi-
ble epileptic cases when they occur at an age that is
deemed incompatible with the suspected syndrome.
Population studies may enrol a large number of sub-
jects but they are less reliable and are often limited
to single geographic areas. Besides, their inability to
enrol a large number of subjects, family studies may
introduce families with a spuriously high number of
epileptic subjects thus inflating the estimated risk.
We assessed the family history of epilepsy in a large
sample of first degree relatives of epileptic probands
followed by the Italian League Against Epilepsy
(LICE). Owing to the large number of subjects enroled
throughout all Italy, we were able to assess family
history also in the least common forms of epilepsy.
METHODS
The Episcreen Project
The Episcreen Project33, 34 is a multicentre longitu-
dinal observational study of epilepsy started in 1994
by the LICE. The Episcreen Project started in 15 Ital-
ian epilepsy clinics for protocol standardisation and
after 2 years extended to 41 centres throughout Italy.
LICE selected the study centres because of the nature
of reference clinics for the diagnosis and treatment of
epilepsy in Italy, taking care that their geographical
distribution was as wide as possible. All consecutive
patients with convulsive disorders seen at the study
centres were enroled in the Episcreen Project.
Classification criteria
The International Classification of Seizures (ICES)
and Epilepsies (ICE) were used for classification
purposes35. Moreover, standardised criteria were de-
veloped for the collection and interpretation of clin-
ical, EEG and neuroradiological data. The following
definitions were adopted for the initial general classi-
fication of idiopathic, symptomatic and cryptogenetic
syndromes.
• Idiopathic: normal clinical and neuroradiological
picture with EEG features consistent with a genetic
origin pattern.
• Symptomatic: evidence of a neurological and/or
intellectual impairment, and/or neuroradiological
evidence of an organic pathology of known or un-
known origin.
• Cryptogenetic: normal clinical and neuroradiolog-
ical picture, without EEG features consistent with
a genetic origin pattern of idiopathic forms.
A complementary sub-classification of epileptic
syndromes was developed with the aim of describing
forms not taken into account by the ICE. A particular
distinction between unclassifiable and unclassified
epilepsies was made and used in the present paper.
We defined ‘unclassifiable’ an epilepsy not classifi-
able despite the availability of a full clinical picture
and ‘unclassified’ an epilepsy for which insufficient
data was available to make a classification.
Data collection
A specific case report form was designed to collect
information from every consecutive patient referring
to the centres, for a new entry visit or a control visit
in the Episcreen data bank. Each centre was also pro-
vided with a computerised system for the storage and
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retrieval of observed data into the local database and
for scheduled data set transmission to the main na-
tional data bank. A Scientific Board was appointed by
LICE as a permanent expert committee. More than 250
descriptive variables were collected to acquire precise
data on patient characteristics and clinical evolution.
Variables included demographic and family history
data, medical history, clinical and diagnostic exami-
nations, therapeutic data and activities of daily living.
Study population and family history data
The sub-set of patients from the Episcreen Project
analysed in this study was selected according to the
following criteria: diagnosed with epilepsy, com-
plete information about family composition and
documented family history. Family history was as-
certained from the medical interview of the proband.
Information about family history were recalled and
confirmed during follow-up visits. A specific inter-
Table 1: Proband’s characteristics and family history of epilepsy and febrile convulsions.
Characteristics N Percent (a) Family history (b) Family history for (c) Family history for epilepsy
for epilepsy (%) febrile convulsions (%) and febrile convulsions (%)
Sex Female 5249 48.7 9.2 3.5 0.7
Male 5538 51.3 7.8 3.1 0.5
Age at onset 0–4 3180 29.5 8.7 4.0 0.5
4–13 4070 37.7 9.4 4.0 0.8
14–19 1191 11.0 9.6 2.6 0.5
20–64 2023 18.8 6.7 1.7 0.4
≥65 323 3.0 3.1 0.3
Age 0–10 2696 25.0 8.2 4.9 0.7
10–20 2803 26.0 10.0 4.2 0.7
20–30 1896 17.6 8.6 2.8 0.5
30–40 1276 11.7 7.8 1.4 0.2
40–50 697 6.5 10.0 2.6 0.4
50–60 557 5.2 6.1 1.8 0.4
≥60 862 8.0 5.7 0.6 0.6
Localisation Focal 6365 59.0 6.2 2.8 0.5
Generalised 3399 31.5 12.6 4.0 0.8
Undetermined 321 3.0 9.7 3.7 0.6
Unclassifiable 308 2.9 7.1 3.2 0.3
Unclassified 394 3.7 11.7 5.1 0.8
Aetiology Idiopathic 3138 29.1 13.4 5.2 1.1
Symptomatic 4311 40.0 5.4 1.6 0.3
Cryptogenetic 2796 25.9 7.4 3.4 0.5
Unknown 542 5.0 10.5 5.5 0.7
Total 10787 100.0 8.5 3.3 0.6
Epileptic syndromes
Idiopathic Focal 941 8.7 9.4 5.0 1.0
Generalised 2159 20.0 15.3 5.3 1.1
Symptomatic Focal 3142 29.1 4.9 1.8 0.3
Generalised 913 8.5 6.2 1.1 0.2
Cryptogenetic Focal 2282 21.2 6.5 3.2 0.5
Generalised 327 3.0 12.2 3.7 0.6
Total family history for epilepsy is given by (a) + (c).
view was conducted in order to ascertain the presence
of relatives affected by epilepsy, febrile convulsions
or both. When an affected relative was recognised,
every effort was made—according to the proband’s
consent—in order to achieve complete medical his-
tory, clinical and diagnostic documentation of his/her
disease. If it was not possible to directly interview
the proband’s relative, or complete information about
his/her epilepsy could not be determined, the relative
was classified as of unknown aetiology. All analyses
of family history of epilepsy were performed consid-
ering only first degree relationships (parents, siblings
and offspring). According to this selection process,
10 787 patients with epilepsy were selected from the
Episcreen database.
Measures of family history
Three measures were used to quantify the family his-
tory of epilepsy in proband’s relatives: (1) prevalence
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of family history (PFH), (2) modified cumulative risk
(MCR) and (3) standardised morbidity ratio (SMR).
PFH is the ratio between the number of relatives with
epilepsy and the total number of first degree relatives.
PFH was calculated for all relatives and for parents,
siblings and offspring separately. MCR allows taking
into account the problem of time exposure to the risk
of epilepsy. Because information about the age at onset
of epilepsy was not always available for proband’s
relatives, MCR was calculated using proband’s age as
a likely correlated variable. Risks were then calculated
for age classes using a life-table approach.
SMR was calculated by standardising PFH on a con-
trol group and summarising the ratio between expected
and observed relatives with epilepsy. Among study pa-
tients with symptomatic epilepsy, 1818 patients with
traumatic, infective, inflammatory, expanding lesion
or post-anoxic causes of epilepsy were considered as
the control group for PFH calculation8, 9. Stratification
for age was made using the following classes: 0–10,
10–20, 20–30, 30–40, 40–50, 50–60 and >60 years. A
further stratification was made for age at onset using
the following classes: 0–4, 5–13, 14–19, 20–64 and
>64 years.
All measures of family history were calculated for
detailed sub-groups of age, sex, localisation and aeti-
ology, and for the overall sample as well.
Table 2: Prevalence of family history (PFH) among first degree relatives.
Total number of first First degree relatives Parents with Siblings with Offspring with
degree relatives (N) with epilepsy (%) epilepsy (%) epilepsy (%) epilepsy (%)
Sex Female 20312 2.8 2.3 3.8 1.8
Male 20232 2.4 2.0 3.2 1.9
Age at onset 0–4 9505 3.2 2.4 5.0 4.3
5–13 13785 3.3 2.4 4.5 4.5
14–19 4667 3.0 2.1 4.3 1.7
20–64 10341 1.5 1.6 1.5 1.4
≥65 2246 0.5 0.2 0.5 0.8
Localisation Focal 24890 1.8 1.5 2.3 1.1
Generalised 12059 4.2 3.1 6.0 4.2
Undetermined 1217 2.9 2.5 3.4 2.8
Unclassifiable 1023 2.4 1.8 3.8 1.6
Unclassified 1355 3.9 3.4 5.0 2.2
Aetiology Idiopathic 10685 4.7 3.3 6.7 6.3
Symptomatic 16805 1.5 1.3 2.1 0.8
Cryptogenetic 11214 2.1 1.9 2.5 1.6
Unknown 1840 3.6 3.0 4.8 2.6
Total 40544 2.6 2.1 3.5 1.9
Epileptic syndromes
Idiopathic Focal 3.4 2.3 5.5 0.0
Generalised 5.3 3.8 7.2 6.9
Symptomatic Focal 1.3 1.2 1.6 0.8
Generalised 2.0 1.5 3.4 0.3
Cryptogenetic Focal 1.8 1.7 2.2 1.5
Generalised 3.8 3.2 4.9 2.5
RESULTS
Ten thousand seven hundred eighty-seven patients
were available for analysis; the total number of first
degree relatives amounts to over 40 000 subjects
(40 544). Table 1 gives the main characteristics of
the study population and the frequency of epilepsy
according to sex, age at onset, localisation and ae-
tiology. Focal forms of epilepsy (59.0%) were more
frequent than generalised forms and the most frequent
aetiology was symptomatic (40.0%). An overall fam-
ily history of epilepsy could be ascertained in 9.1%
of probands; considering also febrile convulsions,
the values goes up to 12.4%. A higher frequency of
family history was seen in generalised than partial
syndromes and, as expected, in idiopathic than symp-
tomatic forms. These results do not take into account
the proband’s family composition and thus give only
types limited picture of the family history of epilepsy.
PFH
A more detailed analysis is given in Table 2, reporting
PFH values for the different proband’s epileptic forms.
Idiopathic (4.7%) and generalised (4.2%) epilepsies
had the higher values of PFH while the lowest ones
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Table 3a: Epilepsy localisation in affected first degree relatives (% row).
Proband Relatives with epilepsy (N) Focal (%) Generalised (%) Undetermined (%) Unknown (%)
Focal 431 33.6 26.0 10.4 29.9
Generalised 501 10.8 64.3 8.8 16.2
Undetermined 35 22.9 22.9 28.6 25.7
Unclassifiable 25 12.0 48.0 8.0 32.0
Unclassified 52 19.2 15.4 19.2 46.2
Total 1044 21.1 44.3 10.6 24.0
Table 3b: Epilepsy aetiology in affected first degree relatives (% row).
Proband Relatives with epilepsy (N) Idiopathic (%) Symptomatic (%) Cryptogenetic (%) Unknown (%)
Idiopathic 493 61.7 5.5 5.7 27.2
Symptomatic 255 12.5 36.5 6.3 44.7
Cryptogenetic 230 22.2 11.3 12.2 54.3
Unknown 66 16.7 16.7 12.1 54.5
Total 1044 38.1 15.0 7.7 39.2
Table 3c: Summary of concordance.
Proband’s localisation Proband’s aetiology
Idiopathic %a (% cellb) Symptomatic %a (% cellb) Cryptogenetic %a (% cellb)
Focal 51.0 (38.8) 33.9 (18.2) 23.2 (8.3)
Generalised 65.4 (56.2) 54.6 (39.4) 69.1 (16.7)
Undetermined 0.0 (0.0) 23.1 (0.0) 35.0 (10.0)
a Concordance between epilepsy in probands and relatives in at least localisation. b Full concordance of epilepsy syndromes (both
localisation and aetiology) between probands and relatives.
Table 4: Modified cumulative risks (MCRs).
MCR in relatives MCR in parents MCR in siblings MCR in offspring
Sex Female 6.87 5.95 8.46 4.19
Male 6.89 7.11 6.94 5.30
Age at onset 0–4 25.76 5.61 34.77 16.59
5–13 27.06 15.11 35.27 36.24
14–19 8.70 9.39 10.54 3.42
20–64 5.05 7.66 4.56 3.11
≥65 0.92 0.16 0.85 1.79
Localisation Focal 4.80 5.02 5.16 3.28
Generalised 11.89 9.67 14.01 9.03
Undetermined 11.17 8.83 9.41 12.50
Unclassifiable 6.35 5.12 7.90 3.03
Unclassified 9.04 9.30 9.60 3.76
Aetiology Idiopathic 34.31 17.48 40.57 24.65
Symptomatic 3.46 3.21 4.19 1.92
Cryptogenetic 7.44 7.59 7.17 6.92
Unknown 9.60 9.18 9.88 6.65
Total 6.87 6.47 7.72 4.78
Epileptic syndromes
Idiopathic Focal 13.69 17.19 15.66 0.00
Generalised 34.61 17.40 40.69 25.82
Symptomatic Focal 3.34 3.21 3.83 2.21
Generalised 3.79 3.14 5.65 0.60
Cryptogenetic Focal 6.60 7.30 5.84 6.50
Generalised 10.39 7.29 14.71 3.50
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Table 5: Standardised morbidity ratios (SMRs).
SMR in relatives SMR in parents SMR in siblings SMR in offspring
Sex Female 3.51 3.57 3.11 11.27
Male 2.49 1.88 3.91 1.52
Age at onset 0–4 2.58 2.29 3.10 1.90
5–13 2.56 2.03 3.07 4.51
14–19 9.18 n.c. 5.53 n.c.
20–64 2.18 1.98 3.17 1.46
≥65 2.01 n.c. 0.53 n.c.
Localisation Focal 1.96 1.69 2.37 1.51
Generalised 4.74 6.65 3.80 4.15
Undetermined 1.41 0.67 n.c. n.c.
Aetiology Idiopathic 3.36 2.77 3.59 7.77
Symptomatica 1.79 1.48 2.20 0.95
Cryptogenetic 1.87 1.88 1.84 1.61
Unknown 2.79 2.64 2.88 2.55
Total 2.92 2.44 3.51 2.76
Epileptic syndromes
Idiopathic Focal 2.03 1.65 2.35 n.c.
Generalised 4.63 6.65 3.24 10.29
Symptomatic Focal 1.46 1.29 1.69 0.97
Generalised 2.67 3.29 2.87 n.c.
Cryptogenetic Focal 1.62 1.56 1.66 1.45
Generalised 3.73 5.29 2.60 2.67
n.c.: not computable.
a Not in control group.
characterised focal (1.8%) and symptomatic epilepsies
(1.5%). A greater prevalence of epilepsy was observed
in relatives of probands with an onset of epilepsy in
the first 13 years of life; the prevalence of epilepsy
then decreases for increasing values of age at onset.
Considering the total number of relatives, PFH was
slightly higher in female then male probands, but the
reverse was seen for offspring. Table 3a and b gives
a classification of epileptic types in proband’s rela-
tives: differently from the proband, generalised types
were the most frequent (44.3%). Because of the lack
of information, 39.2% of epilepsies of relatives were
classified as of unknown aetiology. This makes it dif-
ficult to contrast the aetiology of relatives with that of
probands. However, a comparison of the localisation
in relatives versus probands is still possible. The com-
parison is given in Table 3c. Probands with idiopathic
generalised epilepsy showed the highest concordance
ratio, with 56.2% of relatives affected by the same
form of epilepsy (both in localisation and aetiology).
MCR
MCR is an index of family history adjusted taking into
account the age of probands. The rationale underlying
its use is that the higher the age of relatives, the lower
their probability of developing epilepsy. Because of
the absence of information about the age at onset in
relatives, we used the age of probands as a likely cor-
related variable. Consequently, MCR produces higher
estimates than PFH, because it incorporates the time
of exposure to the risk of epilepsy. MCR are given
in Table 4, showing the highest estimates for rela-
tives of probands with generalised idiopathic epilepsy
(34.6%).
SMR
Table 5 gives SMR for the different proband’s epilep-
tic types. Generalised idiopathic epilepsy showed
the highest value (4.6%) independently from the
aetiology.
DISCUSSION
We performed a ‘multi-way’ analysis of family history
in a very large sample of well-classified epileptic sub-
jects, producing some relevant information based on a
high number of relatives. The fact that the study cen-
tres were widely distributed throughout Italy, allowed
us to recruit a sample of epileptic subjects which is
comparable in distribution and clinical characteristics
to samples obtained from population studies36. Our
data confirm the higher frequency of a family history
in idiopathic generalised epilepsy. In the present study,
the risk of a positive family history was 4.6% higher
in subjects with idiopathic generalised epilepsy than
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controls and this was especially evident in parents
whose risk was 6.6%. The reason why generalised
epilepsy is associated with a high value of a family
history may be due to the high frequency of idiopathic
types (>63%) but this may not be the only reason. Gen-
eralised epilepsies had higher values of PFH and SMR
than focal epilepsies and this was evident not only for
idiopathic types but also for cryptogenetic and symp-
tomatic ones, suggesting an independent contribution
to epilepsy localisation.
This study offers some information about epileptic
types that are not considered in detail by other studies.
In cryptogenetic epilepsies, a prevalence of a family
history was detected in 2.1% of relatives and the SMR
was 1.87. Thus, according to our data, cryptogenetic
epilepsies would stay halfway between idiopathic and
symptomatic epilepsies, suggesting the possibility that
epilepsies with high genetic influence may converge
into this group together with purely secondary forms.
It is also of interest that a high frequency of a fam-
ily history was evident for the undetermined epileptic
types with focal and generalised seizures. This may
be partly explained by the presence in this group of
severe myoclonic epilepsy whose familial component
is well known. Another interesting result derives from
the observation of a non-significant higher family his-
tory in female probands. SMR values (3.51% in fe-
males and 2.49% in males) suggest just this, but MCR
values suggest that this difference may be influenced
by the age of proband’s relatives (in our study, esti-
mated by means of proband’s age). MCR also enabled
us to show high values of a family risk in epilepsies
with a younger age at onset whilst this was not so ev-
ident from prevalence rates alone. The high number
of enroled patients allowed us to compare the epilep-
tic types of probands with those of relatives. Probands
with generalised epilepsy were more likely to have rel-
atives while the same epileptic type. Further analyses
could show other aspects of family history in epileptic
types with low prevalence in population studies.
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